2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Factors Are Propelling the Market Growth of theKidney Disease Market from 2025 to 2034?

The kidney disease market is anticipated to flourish due to the rising prevalence of kidney diseases. These diseases encompass various issues that alter the operation and anatomy of the kidneys. Medications for kidney disorders aim to decrease patients’ blood pressure, lessen protein loss, manage signs, prevent complications, and delay the worsening of kidney damage. For example, Kidney Research UK, a UK-based charity engaged in research and campaigning to enhance comprehension, prevention, and treatment of kidney diseases, reported in June 2023 that an estimated 7.19 million individuals in the UK suffered from chronic kidney disease in 2023, equating to over 10% of the UK population. This figure is predicted to grow to 7.61 million individuals by 2033. Consequently, the escalating prevalence of kidney diseases is fueling the expansion of the kidney disease market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=11938&type=smp

What is the Predicted Annual Growth Rate of theKidney Disease Market Impact Industry Trends by 2034?

The market size for kidney disease has seen significant growth over recent years. The market is expected to expand from $107.29 billion in 2024 to $114.74 billion in 2025, translating to a compound annual growth rate (CAGR) of 6.9%. This rise during the historic period is a result of factors such as increasing chronic health issues, an aging demographic, genetic tendencies, advancements in medical research and education, as well as environmental influences.

The market size for kidney disease is anticipated to experience robust expansion in the coming years. It is projected to escalate to $149.44 billion by 2029, with a compound annual growth rate (CAGR) of 6.8%. The growth expected in this forecast period can be linked to global management of infectious diseases, precision medicine tactics, the epidemic of diabetes and obesity, changes in healthcare policies, and heightened awareness and screenings. Some of the key trends during this forecast period encompass the use of telemedicine for kidney treatment, emphasis on preventive nephrology, increase in home-based dialysis, advancement in regenerative therapies, and adjustments in diets and nutrition.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11938

How Are Market Trends and Innovations Revolutionizing theKidney Disease Industry in Recent Times?

The widespread use of AI-powered tools is a rising trend in the kidney disease market. Businesses in this sector are leveraging new technologies to enhance patient results and maintain their market standing. For example, Carenostics, a healthcare startup from the US that focusses on AI solutions, unveiled its first product in November 2022. This product utilizes AI to scrutinize electronic health record (EHR) data to identify early signs of chronic kidney disease (CKD). The AI-powered models by Carenostics are smoothly amalgamated into the EHR systems used by healthcare providers. This combination allows healthcare professionals to accurately spot patients at high risk of chronic diseases, thereby allowing them to take necessary steps to ensure better patient outcomes.

Which Key Market Players Are Shaping the Future and Growth of theKidney Disease Market?

Major companies operating in the kidney disease market include Pfizer Inc., Johnson & Johnson Ltd., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi Aventis LLC, Bristol-Myers Squibb Company, AstraZeneca Pharmaceuticals LP, Abbott Laboratories, Fresenius SE & Co. KGaA, GlaxoSmithKline Plc., Takeda Pharmaceutical Company Limited, Eli Lilly and Co Ltd., Gilead Sciences Inc., Amgen Inc., Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Vertex Pharmaceuticals Inc., Otsuka Pharmaceutical Co. Ltd., Mitsubishi Tanabe Pharma Corporation, Aurobindo Pharma Limited, Dr. Reddy’s Laboratories Ltd., Kyowa Kirin Co. Ltd., Cipla Inc., Endo International plc., Lupin Limited, Kissei Pharmaceutical Co. Ltd.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/kidney-disease-global-market-report

#thebusinessresearchcompany #marketresearch #marketintelligence

The kidney disease market covered in this report is segmented –

1) By Treatment: Medication, Dialysis, Surgery, Other Treatments

2) By Indication: Acute Kidney Injury, Chronic Kidney Disease, End-Stage Renal Disease, Other Indication

3) By Route Of Administration: Oral, Parenteral

4) By End-User: Hospitals, Diagnostic Laboratories, Other End-Users

Subsegments:

1) By Medication: Antihypertensives, Erythropoiesis-Stimulating Agents (ESAs), Phosphate Binders, Vitamin D Analogs, Immunosuppressants

2) By Dialysis: Hemodialysis, Peritoneal Dialysis

3) By Surgery: Kidney Transplant, Nephrectomy, Renal Artery Bypass, Ureteral Surgery

4) By Other Treatments: Lifestyle And Dietary Modifications, Renal Replacement Therapy, Palliative Care

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=11938&type=smp

What Regions Are Dominating the Kidney Disease Market Growth?

North America was the largest region in the kidney disease market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the kidney disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Gobal Kidney Disease Maret 2025, By The Business Research Company:

Tumor Ablation Therapy Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/tumor-ablation-therapy-devices-global-market-report

Cancer Clinical Decision Tools Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cancer-clinical-decision-tool-global-market-report

Tumor Embolization Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/tumor-embolization-devices-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: